Short-term beat-to-beat variability of the QT interval is increased and correlates with parameters of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy

Orosz, Andrea and Baczkó, István and Nagy, Viktória and Gavallér, Edit Henriette and Csanády, Miklós and Forster, Tamás and Papp, Gyula and Varró, András and Lengyel, Csaba Attila and Sepp, Róbert (2015) Short-term beat-to-beat variability of the QT interval is increased and correlates with parameters of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 93 (9). pp. 765-772. ISSN 0008-4212

Text QT_STV_in_HCM_Orosz_et_al_CJPP_2015_u.pdf Restricted to Repository staff only Download (280kB) | Request a copy

Abstract

Stratification models for the prediction of sudden cardiac death (SCD) are inappropriate in patients with hypertrophic cardiomyopathy (HCM). We investigated conventional electrocardiogram (ECG) repolarization parameters and the beat-to-beat short-term QT interval variability (QT-STV), a new parameter of proarrhythmic risk, in 37 patients with HCM (21 males, average age 48 +/- 15 years). Resting ECGs were recorded for 5 min and the frequency corrected QT interval (QTc), QT dispersion (QTd), beat-to-beat short-term variability of QT interval (QT-STV), and the duration of terminal part of T waves (Tpeak-Tend) were calculated. While all repolarization parameters were significantly increased in patients with HCM compared with the controls (QTc, 488 +/- 61 vs. 434 +/- 23 ms, p < 0.0001; QT-STV, 4.5 +/- 2 vs. 3.2 +/- 1 ms, p = 0.0002; Tpeak-Tend duration, 107 +/- 27 vs. 91 +/- 10 ms, p = 0.0015; QTd, 47 +/- 17 vs. 34 +/- 9 ms, p = 0.0002), QT-STV had the highest relative increase (+41%). QT-STV also showed the best correlation with indices of left ventricular (LV) hypertrophy, i.e., maximal LV wall thickness normalized for body surface area (BSA; r = 0.461, p = 0.004) or LV mass (determined by cardiac magnetic resonance imaging) normalized for BSA (r = 0.455, p = 0.015). In summary, beat-to-beat QT-STV showed the most marked increase in patients with HCM and may represent a novel marker that merits further testing for increased SCD risk in HCM.

Actions (login required)

Edit Item